Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-11

Clinical Trial Update: Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update investigating latency antibiotics for previable preterm premature rupture of membranes (PPROM) with ongoing recruitment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Woman's | Conditions: Rupture of Membranes; Delayed Delivery (Following Spontaneous Rupture), Rupture of Membranes; Premature | Phase 4 | Status: RECRUITING